India Readies 72-Officer Force To Check Imported Drugs
This article was originally published in PharmAsia News
Executive Summary
India's chief regulator says his office is establishing a 72-officer work force to check the quality of imported drugs. Some of the inspectors and technical associates are to be sent to other countries to inspect drugs, a reversal of what has been the usual practice. The traveling inspectors are to begin moving in the first quarter of next year. Surinder Singh, the drug controller general of India, told a conference the DCGI also plans to cooperate with the country's port authorities to address the problem. (Click here for more
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.